(Q24306084)

cholesterol transfer activity

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

coronary artery disease

1 reference

9

Aeilko H Zwinderman

0 references

John J. P. Kastelein

13

object named as

John J P Kastelein

0 references

Erik Stroes

8

object named as

Erik S G Stroes

0 references

G Kees Hovingh

1

object named as

G Kees Hovingh

0 references

author name string

Alison Brownlie

2

0 references

Radjesh J Bisoendial

3

0 references

Marie Pierre Dube

4

0 references

Johannes H M Levels

5

0 references

Wilma Petersen

6

0 references

Robin P F Dullaart

7

0 references

Eric de Groot

10

0 references

Michael R Hayden

11

0 references

Jan Albert Kuivenhoven

Journal of the American College of Cardiology

12

0 references

language of work or name

English

0 references

publication date

6 October 2004

0 references

published in

0 references

volume

44

0 references

issue

7

0 references

page(s)

1429-35

0 references

cites work

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Screening for naturally occurring apolipoprotein A-I variants: apo A-I(?K107) is associated with low HDL-cholesterol levels in men but not in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

HDL and arteriosclerosis: beyond reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

High-density lipoprotein--the clinical implications of recent studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

DMLE+: Bayesian linkage disequilibrium gene mapping.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Measurement of subclinical atherosclerosis: beyond risk factor assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

A cysteine-containing truncated apo A-I variant associated with HDL deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.JACC.2004.06.070

7 January 2021